Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 5, 2002

View Archived Issues

NNC-45-0781, a promising candidate for postmenopausal osteoporosis

Antitumor effects demonstrated for rapamycin at immunosuppressive doses

Influenza vaccination reduces risk of brain infarction according to French researchers

Seattle Genetics and Genencor jointly develop ADEPT products including SGN-17/19

FDA approves BioPort anthrax vaccine license supplements

Preclinical evidence for efficacy of celecoxib in inflammatory bowel disease

Forbes Medi-Tech initiates phase I trial of cholesterol-lowering pharmaceutical

AltaRex offers further analysis of OvaRex results

Corixa reports progress in 2001

Malarex: a natural alternative in the fight against malaria

Chiron and Global Alliance for TB Drug Development collaborate on PA-824

Gleevec approved for gastrointestinal stromal tumors

National Institute on Aging studies genetic traits in Sardinians

Oxigene highlights product developments in fourth quarter 2001

First approval obtained for antihypertensive combination developed in Spain

Clinical testing of candidate HIV vaccine developed at GSK commences in U.S.

Tricyclic compounds that inhibit MRP-1 are useful as oncolytics

Radiolabeled nucleoside compounds for use as cancer imaging and therapeutic agents

Corixa designs isoleucine-containing peptide prodrugs of antitumor agents

Quinazoline derivatives that act as NPY antagonists for eating disorders, etc.

Preparation and use of pipecolic acid derivatives with MMP-inhibitory activity

Aromatic alphavbeta3 and/or alphavbeta5 integrin receptor antagonists disclosed by Pharmacia

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...